Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2023

  1. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

    Infectious Diseases Now, Vol. 53, Núm. 7

2022

  1. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

2020

  1. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  2. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

2016

  1. Impact of cytomegalovirus infection on severe hepatitis c recurrence in patients undergoing liver transplantation

    Transplantation, Vol. 100, Núm. 3, pp. 593-599

2015

  1. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  2. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

2014

  1. Cytomegalovirus infection in solid organ transplant recipients

    Clinical Microbiology and Infection, Vol. 20, Núm. s7, pp. 19-26

  2. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections

    Clinical Microbiology and Infection, Vol. 20, Núm. s7, pp. 10-18

2012

  1. Infection prevention in solid organ transplantation

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. SUPPL.2, pp. 27-33

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Impact of hepatitis C virus infection on the risk of infectious complications after kidney transplantation: Data from the RESITRA/REIPI cohort

    Transplantation, Vol. 92, Núm. 5, pp. 543-549

  4. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  5. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2008

  1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

2007

  1. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA Study Group

    American Journal of Transplantation, Vol. 7, Núm. 4, pp. 964-971

2006

  1. A review of critical periods for opportunistic infection in the new transplantation era

    Transplantation, Vol. 82, Núm. 11, pp. 1457-1462

2005

  1. Consensus document from GESITRA-SEIMC on the prevention and treatment of cytomegalovirus in transplanted patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 7, pp. 424-437

  2. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study

    Clinical Infectious Diseases, Vol. 41, Núm. 1, pp. 52-59